Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Event”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00636766
What this trial is testing

Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque

Who this might be right for
Carotid AtherosclerosisStrokeType 2 Diabetes+1 more
Aristotle University Of Thessaloniki 300
Not applicableStudy completedNCT05900947
What this trial is testing

Pollutants in the Atherosclerotic Plaque and Cardiovascular Events

Who this might be right for
Atherosclerosis
University of Campania Luigi Vanvitelli 312
Not applicableStudy completedNCT03702764
What this trial is testing

Coronary Plaque Geometry and Acute Coronary Syndromes

Who this might be right for
Coronary StenosisAcute Coronary SyndromeAcute Myocardial Infarction+2 more
Cardio Med Medical Center 1,000
Not applicableLooking for participantsNCT06471036
What this trial is testing

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

Who this might be right for
ASCVDLDL-C
Duke University 400
Not applicableUnknownNCT02257333
What this trial is testing

Retinal Thrombosis and Atherosclerosis

Who this might be right for
Retinal Vein Occlusion
University of Roma La Sapienza 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06292013
What this trial is testing

Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company 17,300
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Large-scale testing (Phase 3)Looking for participantsNCT07157774
What this trial is testing

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Who this might be right for
Elevated Lp(a)Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company 10,450
Not applicableActive Not RecruitingNCT05462262
What this trial is testing

Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population

Who this might be right for
Coronary Artery Disease Progression
Chinese Academy of Medical Sciences, Fuwai Hospital 2,900
Not applicableStudy completedNCT07615179
What this trial is testing

Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events
Sanofi 4,545
Not applicableStudy completedNCT06644651
What this trial is testing

Fat Around Heart Arteries as a Measure of Inflammation in Patients With Diabetes

Who this might be right for
Atherosclerosis, CoronaryDiabetes MellitusDiabetes Mellitus Type 2+3 more
Odense University Hospital 314
Not applicableStudy completedNCT07417618
What this trial is testing

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Who this might be right for
Type 2 DiabetesOverweightASCVD
Brigham and Women's Hospital 60,000
Large-scale testing (Phase 3)Study completedNCT03570697
What this trial is testing

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Who this might be right for
Coronary Artery Disease (CAD)
Amgen 164
Not applicableNot Yet RecruitingNCT07511231
What this trial is testing

Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI

Who this might be right for
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Beijing Anzhen Hospital 1,800
Not applicableStudy completedNCT07734753
What this trial is testing

Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic Events

Who this might be right for
Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events
Sanofi 4,006
Not applicableActive Not RecruitingNCT06295679
What this trial is testing

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Who this might be right for
Major Cardiovascular EventEstablished Atherosclerotic Cardiovascular Disease
Amgen 7,000
Not applicableUnknownNCT05545618
What this trial is testing

Brain-heart Interaction in Coronary Plaque Stability and Cardiovascular Events

Who this might be right for
Coronary Artery Disease
Shanghai Zhongshan Hospital 300
Large-scale testing (Phase 3)Active Not RecruitingNCT07000123
What this trial is testing

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 3,103
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Large-scale testing (Phase 3)Study completedNCT00526474
What this trial is testing

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Who this might be right for
AtherosclerosisIschemiaMyocardial Infarction+2 more
Merck Sharp & Dohme LLC 26,449
Next Page